Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

4 Comments

Our feedback of Drug Discovery 2015 in Telford | HCS-pharma · September 14, 2015 at 9:03 am

[…]  first one was about the development of a neuroprotection assay as a Parkinson’s desease model in 2D culture. First results on 3D culture, where we can see the neurites connecting different spheroids, were […]

Elrig » Event in BrusselsElrig · December 2, 2015 at 10:52 am

[…] Operetta machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other posters: hepatotoxicity […]

ELRIGfr » Notre événement de Bruxelles en Octobre 2015ELRIGfr · July 10, 2016 at 4:12 pm

[…] machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other […]

Our feedback of lab automation congress of ELRIGfr in Bruxelles | HCS-pharma · March 16, 2017 at 10:08 am

[…] Operetta machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other posters: hepatotoxicity […]

Leave a Reply